doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:
    Search results
Search results for: weight

1 - 5 of 259 <<previous | next>>

Drugs results:

Diazepam tablets

Diazepam

Diazepam, one of a group of drugs known as Benzodiazepines, is a Central Nervous System (CNS) depressant. Diazepam is used as an Amnestic, an Anitanxiety Agent, Anticonvulsant, an Antipanic and Antitremor Agent, a Sedative, and Muscle Relaxant. It is used more...

Fioricet tablets

Fioricet

Fioricet, a combination of Butalbital, Acetaminophen, and Caffeine, is a pain reliever and relaxant used to treat tension headaches. Butalbital belongs to the group of medicines called barbiturates that act in the Central Nervous System (CNS) to produce t more...

Levitra tablets

Levitra

Levitra is one of a group of medicines that delay enzymes called phosphodiesterases from working too quickly, and is used to treat men who have erectile dysfunction. By controlling these enzymes, Levitra helps men maintain an erection. Levitra is also more...

Meridia

Meridia

Meridia, or Sibutramine, is used together with a reduced-calorie diet to help you lose weight and to help keep the lost weight from returning. Meridia is thought to work by increasing the activity of norepinephrine and serotonin in th more...

Paxil tablets

Paxil

Paxil is used to treat mental depression, obsessive-compulsive disorder, panic disorder, generalized anxiety disorder, social anxiety disorder, premenstrual dysphoric disorder (PMDD), and posttraumatic stress disorder (PTSD). more...

Diseases results:

Status epilepticus
Pain relief
Erectile dysfunction
Obesity
Obsessive compulsive disorder
Gastro problems
Mental Health and Depression
Diabetes
Birth control
Lung cancer

Articles results:

Novo Nordisk Withdraws Its Application To Extend The Marketing Authorisations For NovoNorm And Prandin
The European Medicines Agency has been formally notified by Novo Nordisk A/S of its decision to withdraw its application for a change to the marketing authorisations for NovoNorm (repaglinide) and Prandin (repaglinide) 0.5 mg, 1 mg and 2 mg tablets. NovoNorm was first authorised in the European Union on 17 August 1998 and Prandin on 29 January 2001. Both products are currently indicated for use in patients who have non-insulin-dependent diabetes (type-2 diabetes).


Long Island Newsday Examines American Medical Association Recommendations On Regulation Of Prescription Drug Advertisements
Long Island Newsday on Tuesday examined American Medical Association recommendations on regulation of direct-to-consumer prescription drug advertisements, which have become "ubiquitous" on television, radio, the Internet, and in newspapers and magazines (Mitchell, Long Island Newsday, 10/31).


Novartis Highlights Strong R&D Pipeline, Plans For Multiple New Product Launches And Novel Projects Moving Into Late-stage Trials
Novartis unveiled today new data on its promising pipeline amid plans for multiple new product approvals and launches over the next two years. Many of these anticipated approvals are for potentially best-in-class medicines that would advance treatment standards for patients with hypertension, diabetes, cancer and other diseases.


UIC Receives Grant To Find New Drugs For Bipolar Disorder
Researchers at the University of Illinois at Chicago have been awarded a three-year $2.1 million grant from the National Institute of Mental Health to develop a new drug to treat bipolar disorder.The goal is to develop a compound that is able to enter the brain and block the mania associated with the disease, says principal investigator Alan Kozikowski, professor of medicinal chemistry and pharmacognosy.


FDA Approves Over The Counter Weight Loss Pills
The American Food and Drug Administration (FDA) has approved Orlistat for use as an over the counter weight loss drug for adults who are overweight. The drug, which was originally approved for prescription in 1999, will retain prescription status at higher doses for the medical treatment of obesity. The FDA said that the drug on its own will not work.




1 - 5 of 259 <<previous | next>>

© 2006-2010 pharmacy-and-drugs.com. All rights reserved.